The classification helps answer the question: "What am I actually taking, and how does it compare to what I read about online?" [Diagram suggestion: Four-quadrant matrix with axes labeled "Receptor target" (pure GLP-1 vs multi-agonist) and "Approval status" (FDA-approved vs compounded), with all medications plotted in their respective quadrants] The pattern we see in FormBlends refill data: patients often start on compounded semaglutide (Tier 4), then switch to brand-name Wegovy (Tier 1) when insurance coverage becomes available, then switch to tirzepatide (Tier 3) if weight loss plateaus
Fake profiles and reviews particularly insidious The Maementcurves.com site, portraying itself as Australian, claimed the treatment had even saved the life of a customer who had been seriously obese and close to death and was especially endorsed by Lyndi Cohen, one of Australias leading dietitians
Preserves Muscle: Prevents unwanted muscle loss
They are prepared by licensed compounding pharmacies using ingredients from FDA-regulated suppliers
R., Kelleher, J
Out of all the study participants, 39.6 percent were prescribed semaglutide for type 2 diabetes, 42.6 percent were prescribed liraglutide for type 2 diabetes, 11.1 percent were prescribed semaglutide for obesity, and 6.7 percent were prescribed liraglutide for obesity
